Research Article
[Retracted] Clinical Features and Risk Factors of Fever in Acute Gouty Arthritis
Table 2
Comparison of the clinical characteristics of patients in the fever and non-fever groups.
| Indicators | Fever group (; ) | Non-fever group (; ) | OR | 95% CI | value |
| Sex (men/women) | 47/5 | 107/8 | 0.70 | 0.21–2.26 | 0.553 | Age in (years) | | | — | — | 0.148 | Disease course (year) | | | — | — | 0.830 | White blood cell count (10 ^ 109/L) | | | — | — | 0.005 | Neutrophil proportion (%) | | | — | — | 0.001 | VAS scores | | | — | — | 0.001 | CRP levels (mg/L) | | | — | — | 0.001 | ESR (mm/h) | | | — | — | 0.001 | UA levels (μmol/L) | | | — | — | 0.541 | Body mass index (kg/m2) | | | — | — | 0.041 | Age ≥65 years ( [%]) | 25 (48.1) | 33 (28.7) | 0.44 | 0.22–0.85 | 0.016 | Renal insufficiency ( [%]) | 18 (34.6) | 34 (29.6) | 0.79 | 0.40–1.59 | 0.514 | Hypertension ( [%]) | 29 (55.8) | 56 (48.7) | 0.75 | 0.39–1.45 | 0.397 | Type 2 diabetes mellitus ( [%]) | 11 (21.2) | 17 (14.8) | 0.65 | 0.28–1.50 | 0.310 | Cardiovascular diseases ( [%]) | 9 (17.3) | 14 (12.2) | 0.66 | 0.27–1.65 | 0.373 | NSAID ( [%]) | 37 (71.2) | 83 (72.2) | 1.05 | 0.51–2.17 | 0.892 | Oral hormone therapy ( [%]) | 10 (19.2) | 13 (11.3) | 0.53 | 0.22–1.32 | 0.169 | Oral colchicine therapy ( [%]) | 18 (34.6) | 48 (41.7) | 1.35 | 0.68–2.67 | 0.383 | Betamethasone injection ( [%]) | 38 (73.1) | 54 (47.0) | 0.32 | 0.16–0.67 | 0.002 | NSAIDs combined with betamethasone ( [%]) | 25 (48.1) | 35 (30.4) | 0.47 | 0.24–0.92 | 0.028 |
|
|